SCHEMBL6823634

SCHEMBL6823634

COC(=O)CCCS(=O)(=O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.56
HDAC2 Q92769 2/20 0.56
HDAC8 Q9BY41 2/20 0.56
HDAC3 O15379 1/20 0.56
HDAC4 P56524 1/20 0.56
HDAC7 Q8WUI4 1/20 0.56
HDAC10 Q969S8 1/20 0.56
HDAC11 Q96DB2 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
HDAC9 Q9UKV0 1/20 0.56
HDAC5 Q9UQL6 1/20 0.56
MAPT P10636 1/20 0.53
HSD11B1 P28845 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
KMT2A Q03164 1/20 0.48
KCNH2 Q12809 1/20 0.48
ALDH1A1 P00352 1/20 0.48
HTT P42858 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TP53 P04637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20545500 0.94 HDAC1 (0.66) HDAC1HDAC2HDAC8HDAC3HDAC4
SCHEMBL9703247 0.91 HDAC1 (0.61) HDAC1HDAC2HDAC8HDAC3HDAC4
SCHEMBL28101227 0.90 MAPT (0.59) HDAC1HDAC2HDAC8HDAC3HDAC4
SCHEMBL11452472 0.85 ALDH1A1 (0.62) MAPTKMT2AALDH1A1LMNACA12
SCHEMBL20544598 0.84 HTT (0.65) MAPTL3MBTL1KMT2AALDH1A1HTT
SCHEMBL6336986 0.82 ALDH1A1 (0.68) HDAC1HDAC2HDAC8HDAC3HDAC4
SCHEMBL4711054 0.81 PSIP1 (0.51) MAPTKMT2AALDH1A1HTTNPSR1
SCHEMBL1232793 0.81 HDAC1 (0.57) HDAC1HDAC2HDAC8HDAC3HDAC4
SCHEMBL7862104 0.81 HDAC1 (0.57) HDAC1HDAC2MAPTHSD11B1L3MBTL1
SCHEMBL5128861 0.80 HDAC1 (0.60) HDAC1HDAC2HDAC8HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116606232-A Novel monofluoroalkyl compounds, preparation method and application thereof 许昌学院 2023-08-18 CN disclosed
EP-0871439-B1 SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS AVENTIS PHARMA INC (US) 2004-03-31 EP disclosed
US-6057369-A USE IN THE TREATMENT OF DISEASE STATES ASSOCIATED WITH PROTEINS THAT MEDIATE CELLULAR ACTIVITY WHICH ARE CAPABLE OF BEING MODULATED BY INHIBITING A MATRIX METALLOPROTEINASE (MMP), TUMOR NECROSIS FACTOR (TNF) OR CYCLIC AMP RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 2000-05-02 US disclosed
EP-0871439-A4 SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS RHONE POULENC RORER PHARMA (US) 1999-07-21 EP disclosed
EP-0871439-A1 SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1998-10-21 EP disclosed
WO-1997024117-A1 SUBSTITUTED (ARYL, HETEROARYL, ARYLMETHYL OR HETEROARYLMETHYL) HYDROXAMIC ACID COMPOUNDS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-10 WO disclosed